NCT01465282View on ClinicalTrials.gov

Evaluation of the Efficacy, Safety and Toleration of CT327 Ointment in Patients With Psoriasis Vulgaris

PHASE2CompletedINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions

Psoriasis Vulgaris

Interventions

DRUG

CT327 0.05%

0.05% CT327 (w/w) ointment

DRUG

CT327 0.1%

0.1% CT327 (w/w) ointment

DRUG

CT327 0.5%

0.5% CT327 (w/w) ointment

DRUG

Placebo

Placebo

Trial Locations (13)

Unknown

Hotsprings

San Ramon

Bay City

Fridley

South Euclid

Portland

San Antonio

Spanish Fork

Birmingham

Cardiff

Glasgow

Manchester

Merseyside

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Creabilis SA

INDUSTRY